Answers are grounded in this paper and cite their sources.
Cancer treatment using immune checkpoint blockade (ICB) with anti-programmed cell death protein 1 (αPD-1) and anti-cytotoxic T lymphocyte-associated protein 4 (αCTLA-4) has been successful. However, primary and acquired resistance limits clinical benefit. To improve the effectiveness of ICB therapies, strategies that reorchestrate antitumor immunity through mechanism-based drug combinations are being actively explored. The alkylating chemotherapeutic agent cyclophosphamide (CTX) has direct tumoricidal and immunomodulatory properties, including the induction of homeostatic proliferation of T cells. As ICB suppresses inhibitory signals in T cells, we hypothesized that ICB could augment CTX-induced homeostatic proliferation of antigen-specific T cells, thereby resetting the T-cell receptor repertoire in favor of tumor-specific T cells. In this study, we showed that a single dose of CTX 1 day prior to starting αPD-1 + αCTLA-4 is sufficient to delay tumor progression in established melanoma and prolong survival in tumor-bearing mouse models. These effects extended to other lymphodepleting treatments, such as gemcitabine and radiotherapy. The antitumor immune response was mainly driven by the clonal expansion of activated/effector CD8+ tumor-infiltrating lymphocytes (TIL). Furthermore, combined CTX and αPD-1 + αCTLA-4 treatment demonstrated efficacy across additional preclinical tumor models, including colorectal cancer and triple-negative breast cancer. Overall, these findings highlight that the combination of CTX and ICB represents a clinically relevant approach in the treatment of immunotherapy-refractory tumors. SIGNIFICANCE: Combining lymphodepleting chemotherapy with dual immune checkpoint blockade enhances clonal expansion of effector CD8+ tumor-infiltrating lymphocytes, delays tumor growth, and improves survival, offering a promising strategy for overcoming resistance to immunotherapy.
No takes yet. Share an insight, caveat, or question.
George et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: